DailyIQ
Last updated3 minutes ago

CE·Celanese Corporation

$44.70
+0.14 (+0.31%)
Overnight$44.73+0.03 (+0.07%)
High
$44.81
Open
$44.18
Market Cap
4.91B
52W High
$70.70
Low
$43.60
P. Close
$44.70
P/E
-
52W Low
$35.13
Fwd P/E
7.41
DailyIQ Est.
$63.90
Inst. Ownership
53.3%
Short Interest
5.81%
Days to Cover
3.0
Div. Yield
0.27%
Next Ex-Div
~Oct 28
Technical Score (1D)
32
BEARISH
News Sentiment
57
BULLISH
On Oct 13, Barclays announced it would begin covering Celanese Corp. at an equal‑weight rating, indicating a neutral stance toward the company’s valuation. The bank’s coverage launch signaled that it had completed an initial assessment of Celanese’s financial health and market position, but no new earnings guidance or material corporate action was disclosed. On the same day, RBC Capital maintained a Sector Perform rating for Celanese and raised its price target from $45 to $46, reflecting confidence in the company’s recent performance and outlook. Both developments were reported on Oct 13 and provide investors with updated assessments from two major financial institutions.
LOW TARGET
$46 +2.8%
2 analysts
MEAN TARGET
$61 +36.5%
11 analysts
HIGH TARGET
$86 +92.3%
14 analysts
PRICE RANGE
$46.00 - $86.00
SB / B / H / S / SS
8/9/8/1/1
DAILYIQ EST.
$63.90 (+42.9%)
Sector
Basic Materials
Industry
Chemicals
Exchange
NYQ
Country
United States
Symbol
CE
Description
Celanese Corporation is a global manufacturer specializing in engineered polymers and acetyl products. The company's core business revolves around two primary segments: Engineered Materials, which provides a diverse range of polymers for various industries, and the Acetyl Chain, focused on producing acetyl-based chemicals. Celanese's products are integral to numerous end-markets, including automotive, medical, consumer electronics, and construction, offering solutions for a wide array of applications. Distributing its products directly and through distributors, Celanese serves original equipment manufacturers and suppliers worldwide, leveraging a portfolio of established brands to maintain its market presence. Founded in 1912, Celanese Corporation is headquartered in Irving, Texas.
Bought (1Y)
5,053 shares
$230K
Sold (1Y)
0 shares
$0
Kyrish ChuckSVP & CFO
Buy800 shares2026-08-14
Kyrish ChuckSVP & CFO
Buy100 shares2026-08-14
Kyrish ChuckSVP & CFO
Buy1,400 shares2026-08-14
Duffie Ashley BSVP & GC
Buy600 shares2026-08-11
Murray Mark ChristopherSVP - Acetyls
Buy2,153 shares2026-08-11
48/ 100
Neutral / mixed
Overall: Neutral
✕Revenue declining year over year
✕Negative net margin
✓Positive operating cash flow
Gross Margin
20.5%
Net Margin
-12.2%
Revenue CAGR
2.2%
Current Ratio
1.55x
Debt / Equity
3.41x
Return on Equity
-28.8%
Earnings Summary
Celanese Corporation, a long‑standing player in the basic materials sector, specializes in engineered polymers and acetyl products that serve automotive, medical, consumer electronics, and construction markets, operating through Engineered Materials and Acetyl Chain segments. In the most recent two quarters, Q4 2025 and Q1 2026, revenue slipped from $2.20 billion to $2.34 billion, a modest year‑over‑year decline, while EPS fell from $0.67 to $0.85, reflecting a slight acceleration in earnings growth after a lower Q4 2025 result; both quarters beat analyst EPS estimates, with Q4 2025 exceeding the $0.94 estimate and Q1 2026 narrowly beating the $0.875 estimate. Historically, Celanese has shown a steady YoY revenue growth trajectory, with Q2 2026 revenue at $2.75 billion up 6% from the prior year, and EPS consistently beating estimates in the last four quarters, indicating resilient profitability despite occasional revenue dips. Recent news highlights include Barclays’ October 13 coverage launch and RBC Capital’s rating upgrade, both signaling institutional confidence, and an October 9 price‑increase announcement for select polyamide products aimed at offsetting cost pressures, which may support future margin stability.

EPS

EstBeatMiss
$0.40$0.98$1.56$2.14$2.72Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.56 - -
Q2'26$2.30$2.45+6.6%
Q1'26$0.87$0.85-2.8%
Q4'25$0.94$0.67-28.6%
Q3'25$1.22$1.34+9.6%
Q2'25$1.40$1.44+2.8%

Revenue

EstBeatMiss
$2.1B$2.3B$2.5B$2.7B$2.9BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$2.7B - -
Q2'26$2.8B$2.8B-2.7%
Q1'26$2.4B$2.3B-2.5%
Q4'25$2.3B$2.2B-5.1%
Q3'25 - $2.4B -
Q2'25 - $2.5B -

Market Data

CE Stock Snapshot

BEARISH32/100
$44.73+$0.03 (0.1%)
Market cap
4.91B
Day range
$43.60 – $44.81
News sentiment
57/100 · Neutral
Analyst target
$61.06 (+36.5%)
Consensus
Buy · 27 analysts
52-week range+27.3% off low · -36.7% from high
$35.13$70.70
Price $44.73 DailyIQ Est. $63.90

Momentum has rolled over on Celanese Corporation, which is what drives the bearish read. At this size, a single catalyst moves the stock further than it would a larger peer.

Reverse DCF

What growth is priced into CE?

CHEAP

At today's price, Celanese Corporation needs to grow free cash flow about -2.3% a year for the next 10 years to justify its valuation at a 6.32% cost of capital. Over its actual history it has compounded free cash flow at 8.6% a year, so the market is asking for 10.9 percentage points below its own delivered rate. On that basis CE looks priced below what its own growth record supports.

Implied FCF growth
-2.3%
Historical FCF CAGR
8.6%
Growth gap
-10.9 pts
Verdict
CHEAP
Discount rate (WACC)
6.32%
Beta
1.20

Behaviour On Record

What CE's own history says about today's numbers

Realized volatility (21d)
41.4% 81st pct
Below its peak
-74.1%
vs 200-day average
-12.3%
Up days (1y)
49%

Celanese Corporation is currently running 41.4% annualised volatility over the last 21 sessions. Measured against CE's own 13 years of daily returns rather than a market-wide average, that is the 81st percentile — elevated for this stock, against a typical reading of 27.9%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

CE is trading -74.1% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -24.6%, and the deepest was -61.0% in 2024. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.

Price sits -12.3% from its 200-day moving average. Against every other day in its history, that gap ranks at the 19th percentile — a narrower gap than it typically runs. Over the past year CE closed higher on 49% of sessions, and it is currently 2 sessions into a rising streak.

On October specifically: over 13 years of records, CE finished the month higher 8 of 13 times, with a median return of +2.0% and an average of +1.1%. Its strongest month historically has been April at +3.7% on average, its weakest June at -2.5%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: CE has opened more than 2% away from the prior close in 191 of 3,266 sessions (5.8% of the time), with the largest gaps running +6.8% and -8.0%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, CE moved an average of 6.5% in the session after earnings, closing higher 0 of those 3 times, with a median move of -7.6% and a largest of -9.8%.

All figures computed from 3,267 daily closes between 2013-10-14 and 2026-10-09, split-adjusted, recomputed daily. Percentiles are against CE's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of CE's sector?

Celanese Corporation sits in the Materials sector, currently ranked 9th of 12 GICS sectors by relative-strength rotation score (improving).

Sector rank
#9 of 12
Sector state
Improving
Sector rotation score
9

Analyst Rating Changes

Are analysts turning bullish or bearish on CE?

RBC Capital most recently reiterated its rating on Celanese Corporation to Sector Perform on Oct 13, 2026 with a price target of $46 (from $45). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
RBC Capital — Sector Perform
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Oct 13, 2026RBC CapitalMaintainedSector Perform$45 → $46
Oct 13, 2026BarclaysInitiatedEqual-Weight$49
Sep 30, 2026CitigroupMaintainedBuy$60 → $58
Sep 11, 2026KeybancInitiatedOverweight$57
Aug 6, 2026Wells FargoMaintainedOverweight$80 → $65
Aug 5, 2026BMO CapitalMaintainedMarket Perform$57 → $54
Jul 16, 2026Morgan StanleyMaintainedEqual-Weight$72 → $58
Jul 6, 2026BMO CapitalMaintainedMarket Perform$80 → $57
Jul 1, 2026MizuhoMaintainedNeutral$65 → $55
Jun 30, 2026B of A SecuritiesMaintainedBuy$72 → $63
Jun 24, 2026CitigroupMaintainedBuy$80 → $68
May 12, 2026JP MorganUpgradeNeutral → Overweight$68

Peers & ETF holders

CE peers & ETF holders

News Sentiment Analysis

Sentiment gathered from recent headlines

57/100
Strong NegativeNeutralStrong Positive
MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Barclays announced it would begin covering Celanese Corp. at an equal‑weight rating, indicating a neutral stance toward the company’s valuation. The bank’s coverage launch signals that it has completed an initial assessment of Celanese’s financial health and market position. No immediate earnings guidance or material corporate action was disclosed, so the announcement is largely informational. The coverage may influence investor perception but does not represent a significant catalyst for the stock.
What did this article say?
RBC Capital analyst Arun Viswanathan maintained a Sector Perform rating for Celanese (NYSE:CE) and increased the price target from $45 to $46. The upgrade reflects confidence in the company’s recent performance and outlook. The adjustment signals a modest positive view for the stock, but does not represent a significant shift in valuation or strategy.
What did this article say?
Barclays analyst Aleksey Yefremov initiated coverage on Celanese (NYSE:CE) with an Equal‑Weight rating and announced a price target of $49. The move signals confidence in the company’s prospects and provides a benchmark for investors.
What did this article say?
Celanese Corporation announced on October 9, 2026 that it would raise prices for select polyamide products sold in the Americas, effective from October 19, 2026. The increase was justified by ongoing cost pressures and changing market conditions, aiming to maintain supply reliability and product quality. The company noted that some grades could see higher increases than the baseline. The move is intended to protect margins while continuing to serve customers with high-quality specialty materials.
What did this article say?
Celanese Corporation scheduled an investor event for December 9, 2026, at its technical center and manufacturing site in Florence, Kentucky. The event will feature presentations by CEO Scott Richardson and other executives on business strategy, growth plans, and long-term value creation. A live webcast and Q&A session will be available, with limited in-person attendance due to venue capacity.
What did this article say?
Celanese Corporation announced that it will host a third‑quarter 2026 earnings conference call on November 3, 2026, at 10:00 a.m. ET. The call will be available via webcast and by phone, with a replay accessible until November 17, 2026. The company will release its earnings press release after the market close on November 2, 2026, and provide prepared remarks on its investor website. No financial results or guidance were disclosed in the announcement, and the information is routine for investors. The disclosure does not indicate any material change in the company’s outlook.
What did this article say?
Citigroup analyst Patrick Cunningham reduced Celanese’s price target from $60 to $58 while keeping a Buy recommendation. The downgrade reflects a reassessment of the company’s valuation, suggesting a modest negative outlook for the stock. The move signals a slight shift in sentiment from previous guidance, potentially impacting investor expectations.
What did this article say?
Celanese’s recent acquisition of DuPont’s specialty chemicals unit added approximately $11 billion of net debt to its balance sheet, tightening its leverage profile. The transaction also diluted operating margins, as the acquired business operates at lower profitability levels. Management acknowledged the debt impact but highlighted potential long‑term synergies. The market reacted by pricing in a modest downside to the stock, reflecting concerns over the immediate financial strain.
What did this article say?
Celanese Corporation announced immediate price hikes for four acetyl products, including acetic acid, vinyl acetate monomer, ethyl acetate, and acetic anhydride, on September 21. The increases, ranging from $0.06 to $0.10 per pound, apply in the United States and Canada and are subject to existing contracts. The move is intended to improve operating margins amid rising input costs and a favorable market environment. By adjusting pricing, Celanese aims to offset cost pressures and enhance profitability. The announcement signals management’s confidence in sustaining higher revenue streams.

Technical Analysis

Real-time indicators across multiple timeframes

32
BEARISH
Momentum rank against about 1,000 stocks and ETFs for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $2.61B combined position · 17 adding, 8 trimming, 0 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
BlackRock, Inc.▲ Buy13,362,50012.18%$614.68M2026-08-07
Vanguard Group Inc▲ Buy11,840,34110.79%$500.61M2026-01-29
Norges Bank▲ Buy9,342,8118.51%$429.77M2026-08-12
Capital Research Global Investors▼ Sell3,752,3563.42%$172.61M2026-08-12
Capital World Investors▼ Sell3,049,8432.78%$140.29M2026-08-12
Geode Capital Management, LLC▲ Buy1,995,0861.82%$91.81M2026-08-12
Millennium Management LLC▲ Buy1,635,1331.49%$75.22M2026-08-14
Bank of America Corp▼ Sell1,360,4381.24%$62.58M2026-08-14
Morgan Stanley▼ Sell1,253,7061.14%$57.67M2026-08-13
Goldman Sachs Group Inc▲ Buy1,224,6911.12%$56.34M2026-08-14
Balyasny Asset Management L.P.▲ Buy1,222,4601.11%$56.23M2026-08-14
Citadel Advisors LLC▲ Buy1,221,6101.11%$56.19M2026-09-02
GoldenTree Asset Management LP▲ Buy1,095,3921.00%$50.30M2026-08-14
FMR LLC (Fidelity)▼ Sell906,2720.83%$41.69M2026-08-13
Northern Trust Corp▲ Buy761,8320.69%$35.04M2026-08-13
Point72 Asset Management, L.P.▲ Buy617,2660.56%$28.39M2026-08-14
Invesco Ltd.▲ Buy527,1520.48%$24.25M2026-08-14
Wellington Management Group LLP▼ Sell462,1990.42%$21.26M2026-08-14
Two Sigma Investments, LP▼ Sell436,4760.40%$20.08M2026-08-14
Gotham Asset Management, LLC▲ Buy319,2360.29%$14.68M2026-08-14
Adage Capital Partners GP, L.L.C.▲ Buy315,0000.29%$14.49M2026-08-14
JPMorgan Chase & Co▼ Sell268,2620.24%$12.55M2026-08-12
Susquehanna International Group, LLP▲ Buy270,9450.25%$12.46M2026-08-14
Squarepoint Ops LLC▲ Buy232,6050.21%$10.70M2026-08-14
Wells Fargo & Company▲ Buy177,9160.16%$8.18M2026-08-14
Q2 2026 flow:12.14M sh bought ($558.46M)2.69M sh sold ($124.77M)net +9.45M sh (+$433.70M)
Congressional Trading Activity
3 disclosed trades · ~$91.0K est. traded value · 2 buys, 1 sells
MemberChamberStateTypeAmountTradedFiled
Tommy TubervilleSenateAL▼ Sell$1K - $15K2022-03-302022-04-08
Tommy TubervilleSenateAL▲ Buy$1K - $15K2021-03-292021-07-23
John HoevenSenateND▲ Buy$50K - $100K2019-05-302019-06-03